Category: Pharmaceutical

According to Fact MR’s recent market research, Dyslipidemia Therapeutics sales to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Dyslipidemia Therapeutics market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

 Request Sample –   https://www.factmr.com/connectus/sample?flag=S&rep_id=2928

Digital Transformation in Healthcare Presenting Opportunities for Dyslipidemia Therapeutics Market Growth

Healthcare organizations around the world are deploying digital tools to accommodating changing consumer preferences. They are pressing on solving the long-standing challenge pertaining to care model innovation.

Considering this, the focus on making healthcare affordable and more transparent will increase. Adoption of care model innovation in healthcare will have a profound impact on the Dyslipidemia Therapeutics market.

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Dyslipidemia Therapeutics market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Dyslipidemia Therapeutics

The report offers actionable and valuable market insights of Dyslipidemia Therapeutics. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Dyslipidemia Therapeutics Market across various industries and regions.

This newly published and insightful report sheds light on Market Insights of Dyslipidemia Therapeutics, key dynamics, their impact on the overall value chain from suppliers to end-users and Growth of Dyslipidemia Therapeutics Market.

According to a recently released Fact.MR study, revenues from dyslipidemia therapeutics market surpassed US$ 36 billion in 2018. Low-density lipoproteins held approximately two-thirds of revenues from dyslipidemia therapeutics worldwide in 2018. As high LDL levels have been associated with increased risks of heart attacks, strokes, and other cardiovascular problems in humans, governments around the world are launching various campaigns to raise awareness about the adverse impact of high LDL levels in the blood.

The growing prevalence of cardiovascular disorders worldwide has prompted individuals to effectively manage their LDL levels. To capitalize on the current trends prevalent in the dyslipidemia therapeutics market, pharmaceutical companies continue to strive towards developing new and improved therapies to lower LDL levels, and effectively manage the percentage of other lipids in the blood. A range of new treatments such as combination therapies, gene editing, and novel target drugs are under development, particularly for dyslipidemia therapeutics.

Statins Persist as Preferred Drug Class for Dyslipidemia Therapeutics

Fact.MR estimates the sales of statins for dyslipidemia therapeutics to exceed $20,000 million in 2019. Statins continue to remain the first line of drugs prescribed by doctors to manage and treat dyslipidemia. Statin drugs are deemed useful in reducing LDL levels in humans, with their effectiveness in lowering LDL level being approximately 60%.

 Report Methodology-  https://www.factmr.com/connectus/sample?flag=RM&rep_id=2928

Clinical trials commend statin drugs to substantially reduce the risk of cardiovascular diseases, while stabilizing the blood vessels lining and reducing inflammation. Its ability to aid in blood vessel relaxation also contributes to lowering blood pressure in patients.  Moreover, the growing prevalence of chemoprophylaxis, caused by consumption of statins is further expected to bolster demand for dyslipidemia therapeutics as a consequence.

Gains from other drugs for dyslipidemia therapeutics are expected to remain gradual, with demand arrested by concerns regarding side-effects of statins. There has been a notable rise in the development of alternative drugs, owing to certain health impacts associated with the consumption of statins including muscular pain, the onset of type 1 diabetes, and hemorrhagic stroke.

Non-statins and PCSK9 have witnessed widespread acceptance as an alternative to statins in dyslipidemia therapeutics. Furthermore, with research towards the use of nutraceuticals in clinical practices for dyslipidemia treatment intensifying, pharmaceutical companies are expected to witness significant opportunities in the functional food space.

North America Remains Lucrative for Dyslipidemia Therapeutics Market

The high consumption of fast food and stressful lifestyle of the North American population is one of the key reasons behind the growing incidences heart diseases in the continent. According to a report released by the Centers for Disease Control and Prevention (CDC) cardiovascular diseases were found to be the top cause of deaths in the United States of America in 2017. Another report from the CDC suggested a total of 48.6% US adults were eligible for statin therapy signifying the high prevalence of dyslipidemia in the country. Consequently, the sales of dyslipidemia therapeutic drugs are likely to stay high and the Fact.MR study estimates that the dyslipidemia therapeutics market will witness a growth of 2.9% through 2019.

Apart from North America, China presents lucrative opportunities for the dyslipidemia therapeutics market where the condition was identified as the key cause behind increasing incidences of cardiovascular diseases in the country. Following the discovery, the China Clinical Control of Dyslipidemia (CCCD) has been continuously releasing guidelines to reduce the condition in the country. These factors are likely to aid in the progression of the dyslipidemia therapeutics market in the country.

The Fact.MR report offers forecast of the dyslipidemia therapeutics market for the period 2018-2028. According to the report, the dyslipidemia therapeutics market is projected to record 2.5% CAGR through 2028.

Dyslipidemia Therapeutics Market – Segmentation

The dyslipidemia therapeutics market report offers a detailed analysis of the dyslipidemia market on the basis of different segments. A comprehensive analysis of each of the dyslipidemia therapeutics market segments on the basis of value, Y-o-Y growth, revenue share, and CAGR has been provided in the report.

The dyslipidemia therapeutics market has been segmented on the basis of drug class, distribution channel, type, and region.

Full Access of this Exclusive Report is Available at-  https://www.factmr.com/checkout/2928

Report Benefits & Key Questions Answered

• Dyslipidemia Therapeutics Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
• Dyslipidemia Therapeutics Historical volume analysis: The report provides a comparison of Dyslipidemia Therapeutics’s historical sales and projected sales performance for 2021-2031.
• Dyslipidemia Therapeutics Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Dyslipidemia Therapeutics market. It carefully gauges the impact of changing healthcare needs of key demographics globally
• Dyslipidemia Therapeutics Consumption by demographics: The report investigates consumer behavior affecting Dyslipidemia Therapeutics demand outlook for the assessment period. Effect of their keenness for digital trends on Dyslipidemia Therapeutics market is carefully analyzed
• Post COVID consumer spending on Dyslipidemia Therapeutics: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Dyslipidemia Therapeutics market growth.

For More Insights-  https://www.einpresswire.com/article/556509410/demand-from-personal-care-cosmetic-products-to-drive-the-growth-of-solid-sericin-in-skincare

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

As per Fact.MR, a market research and competitive intelligence provider, the global fluoroscopy equipment market is anticipated to top US$ 3.5 Bn by 2031, progressing at a CAGR over 6% over the forecast period of 2021 to 2031.

Fluoroscopy is a type of medical imaging that uses a monitor to display a continuous X-ray image. It consists of a fluorescent screen and an X-ray source. Fluoroscopy devices are primarily used in medical applications and are helpful in diagnosing health conditions and treating patients.

Growing adoption of interventional radiology procedures that require real-time imaging, such as fluoroscopy, is driving the market. Because of their ability to perform efficient real-time injury assessment in athletes, hand-held fluoroscopes are getting prominence in emergency care. Rise in occurrences of pain treatment and injuries, growing focus among healthcare professionals about fluoroscopy use, and rising prevalence of cardiovascular diseases are all contributing to fluoroscopy equipment market growth.

For detailed insights on enhancing your product footprint, request a sample here- https://www.factmr.com/connectus/sample?flag=S&rep_id=267

Market Segmentation

By Product Type

• Remote-Controlled Fluoroscopy Systems
• Conventional Fluoroscopy Systems
• C-Arms Systems

By End User

• Hospitals
• Diagnostic Center

By Application

• Cardiology
• Gastroenterology
• Urology and Nephrology
• Neurovascular

For comprehensive insights on this market adoption, ask an analyst here- https://www.factmr.com/connectus/sample?flag=AE&rep_id=267

By Region

• North America
• Latin America
• Europe
• Japan
• APEJ
• MEA

Factors Fuelling Growth of the Global Fluoroscopy Equipment Market

Emerging technology has led to several innovations including artificial intelligence, wearable, Internet of Things, and 3D printing. With rapid development, technology continues to maintain a strong grip in the healthcare industry. In a bid to offer medical devices equipped with enhanced services, manufacturers operating in the healthcare industry are increasingly integrating the advanced technology in several medical devices. A research recently conducted reveals that several manufacturers in the healthcare industry are integrating technically enhanced tools such as Google Glass and HoloLens launched by Microsoft in the medical devices that are wearable that are used for visual overlays. These wearable devices enable the end users to get information, which help in the treatment process attributed to the image guided intervention.

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=267

Besides healthcare industry, fluoroscopy devices also witness considerable adoption in the aviation industry. Adoption of fluoroscopy devices is projected to remain concentrated in the aviation industry attributed for scanning hidden weapons and bombs. Unlike the medical devices, the fluoroscopy devices used in the aviation industry have comparatively low impact of radiation on the gadgets, luggage, and food products that are scanned.

Although the overall outlook on growth of the fluoroscopy equipment market looks positive, however, strong need to maintain quality standards continues to hinder growth of the global market for fluoroscopy equipment. One marker gap is further attributed to the investigations conducted by FDA, which ensures the level of quality remains high. However, lack of investment and support from the government is likely to hinder growth of the global market of fluoroscopy equipment.

Hospital to Represent a Dominant Segment

Conventional products is expected to sell more than the remote-controlled products in the healthcare industry. Sales of the conventional products is likely to generate significant revenues in the healthcare industry globally. Currently, the conventional product type segment is projected to represent more than US$ 400 Mn in the global market of fluoroscopy equipment by 2022-end.

With growing need for treatment of cancer in the healthcare industry, the hospitals are likely to represent the major end user globally. Increasing adoption for treatment of cancer in the healthcare industry is projected to rev up the sales of the fluoroscopy equipment globally. The hospital end user segment is projected to represent more than US$ 400 Mn by 2017-end. The diagnostic centres and the other end user segment will also contribute towards growth of the global market through 2022. Demand for the fluoroscopy equipment will continue to remain concentrated towards treatment of cardiology diseases. The cardiology application type segment is represent more than US$ 300 Mn by 2022-end. However, gastroenterology application type segment is projected to represent a relatively high CAGR in the global market of fluoroscopy equipment throughout 2022.

For More Insights: http://www.globenewswire.com/en/news-release/2020/03/27/2007702/0/en/Tricuspid-Valve-Repair-Market-Poised-for-Astounding-Growth-Through-2029-Fact-MR-Projects-Annuloplasty-Rings-to-Remain-Top-Selling.html

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

The global antibodies market study presents an all in all compilation of the historical, current and future outlook of the market as well as the factors responsible for such a growth. With SWOT analysis, the business study highlights the strengths, weaknesses, opportunities and threats of each Antibodies Market player in a comprehensive way. Further, the antibodies market report emphasizes the adoption pattern of the antibodies across various industries.

The antibodies market report highlights the following players:

• Bio-Rad Laboratories, Inc
• Cell Signaling Technology
• Genscript Biotech Corporation
• Sigma Aldrich Corp
• Crown Bioscience, Inc

The antibodies market report examines the operating pattern of each player – new product launches, partnerships, and acquisitions – has been examined in detail.

Request Sample Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=194

Important regions covered in the antibodies market report include:

• North America (S., Canada)
• Latin America (Brazil, Mexico, Argentina, Rest of Latin America)
• Europe (Germany, Italy, France, U.K., Spain, Benelux, Russia, Rest of Europe)
• Japan
• APEJ
• MEA

The antibodies market report takes into consideration the following segments by product type:

• Immune Checkpoint Antibodies
• Epitope Tag Antibodies
• Isotype Control Antibodies
• Primary Antibodies
• Assay Antibodies (includes secondary antibodies)
• Other

The antibodies market report contain the following end uses:

• Biopharmaceutical Companies
• Contract Research Organizations (CROs)
• Academic & Research Institutes
• Forensic Science Laboratories
• Food & Beverage Companies
• Diagnostic Centers
• Others

The antibodies market report offers a plethora of insights which include:

• Changing consumption pattern among individuals globally.
• Historical and future progress of the global antibodies market.
• Region-wise and country-wise segmentation of the antibodies market to understand the revenue, and growth lookout in these areas.
• Accurate Year-on-Year growth of the global antibodies market.
• Important trends, including proprietary technologies, ecological conservation, and globalization affecting the global antibodies

The antibodies market report answers important questions which include:

• Which regulatory authorities have granted approval to the application of antibodies in healthcare industry?
• How will the global antibodies market grow over the forecast period?
• Which end use industry is set to become the leading consumer of antibodies by 2022?
• What manufacturing techniques are involved in the production of the antibodies?
• Which regions are the antibodies market players targeting to channelize their production portfolio?

The antibodies market report considers the following years to predict the market growth:

• Historic Year: 2012 – 2016
• Base Year: 2012
• Estimated Year: 2016
• Forecast Year: 2017 – 2022

Access Research Methodology Prepared By Experts – https://www.factmr.com/connectus/sample?flag=RM&rep_id=194

Why Choose Fact.MR?

Fact.MR follows a multi- disciplinary approach to extract information about various industries. Our analysts perform thorough primary and secondary research to gather data associated with the market. With modern industrial and digitalization tools, we provide avant-garde business ideas to our clients. We address clients living in across parts of the world with our 24/7 service availability.

For More Insights- https://www.biospace.com/article/ongoing-research-and-progress-in-clinical-trials-are-creating-growth-prospects-for-non-hormonal-steroid-modulators-market-fact-mr/

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com

Global Operating Room Equipment market – A report by Fact.MR

Fact.MR, in its latest business intelligence study, depicts the nuts and bolts of the global Operating Room Equipment market. The Operating Room Equipment report presents detailed information regarding the drivers, restraints, opportunities and trends affecting market growth. Each segment alongwith its sub-segment is analyzed in terms of value and volume. Further, the Operating Room Equipment report elaborates the market behavior of each vendor operating in the Operating Room Equipment market.

Request Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=192

Key findings of the Operating Room Equipment market study:

• Regional breakdown of the Operating Room Equipment market based on predefined taxonomy.
• Innovative manufacturing processes implemented by Operating Room Equipment vendors in detail.
• Region-wise and country-wise fragmentation of the Operating Room Equipment market to grasp the revenue, and growth outlook in these areas.
• Changing preferences among consumers across various regions and countries.
• Factors (Positive and Negative) impacting the growth of the global Operating Room Equipment market.

Scope

The scope of Fact.MR’s report is to analyze the global operating room equipment market for the forecast period 2017-2022 and provide readers an unbiased and accurate analysis. Medical device manufacturers, research institutes, and raw material suppliers in the global operating room equipment market can benefit from the analysis offered in this report. This report offers a comprehensive analysis, which can be of interest to leading trade magazines and medical journals pertaining to vaccine delivery devices.

Speak with an Analyst to learn more (methodology)  https://www.factmr.com/connectus/sample?flag=RM&rep_id=192

On the basis of region, the Operating Room Equipment market study contains:

• North America,Europe,Japan,APEJ,MEA

Queries addressed in the Operating Room Equipment market report:

• How has the global Operating Room Equipment market grown over the historic period of 2014-2018?
• Why are the Operating Room Equipment market players targeting region for increased product sales?
• What patented technologies are the players utilizing in the global Operating Room Equipment market?
• Which regions are displaying the fastest growth in the Operating Room Equipment market?
• What are the underlying micro- macroeconomic factors affecting the global Operating Room Equipment market?

Get Full Access of the Report  https://www.factmr.com/report/192/operating-room-equipment-market

Why choose Fact.MR?

Reports published by Fact.MR are a result of the combination of our experts and digital technologies. We thrive to provide innovative business solutions to the clients as well as tailor the reports aligning with the clients’ requisites. Our analysts perform comprehensive research to offer ins and outs of the current market situation. Clients across various time zones tend to utilize our 24/7 service availability.

For More Insights- https://www.einpresswire.com/article/556334535/retail-industry-to-augment-the-demand-for-wi-fi-electronic-shelf-label-over-the-assessment-period

About Fact.MR        

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

In its recent study, Fact.MR projects the global market for liver cancer diagnostics to exhibit a steady rise at 5.5% CAGR throughout the forecast period 2017 to 2022.

The fifth most prevalent cancer, liver cancer, caused 9.1% deaths among the overall population affected with cancer across the globe in 2012. Extreme aggressiveness and poor survival rate related to liver cancer has pushed this disease in becoming a crucial health issue worldwide. A slew of risk factors are associated with liver cancer including infection pertaining to hepatitis C virus (HCV), diabetes, obesity, diabetes, obesity, exposure to dietary aflatoxin, alcohol-induced cirrhosis, hepatitis B virus (HBV). With the capability of modification of these risk factors, strong prospects have been offered to lower its prevalence and mortality, by utilizing preventive strategies such as lifestyle modification, and hepatitis immunization. These factors are expected to fuel demand for liver cancer diagnostics across the globe.

Request 100 Page Sample Report Now https://www.factmr.com/connectus/sample?flag=S&rep_id=73

Hepatocellular carcinoma (HCC), or, liver cancer is predicted to cause numerous deaths annually. With an aim of preventing liver cancer in reaching its final stage, the scientists across the world are developing a number of improved treatments as well as vaccines. Newer techniques developed for therapeutics of liver cancer render both liver transplant as well as partial hepatectomy more effective and safer. Leading medical research institutes worldwide are concentrating on development of advanced tests for complete diagnosis  of liver cancer. The aforementioned factors are further estimated to drive growth of the global liver cancer diagnostics market over the forecast period.

Request Customization https://www.factmr.com/connectus/sample?flag=RC&rep_id=73

Takeaways from the Global Liver Cancer Diagnostics Market

1. In terms of revenues, North America will remain the most lucrative region in the global market for liver cancer diagnostics. In addition, liver cancer diagnostics markets in North America and Europe will exhibit expansion at similar CAGRs through 2022.
2. Liver cancer diagnostics markets in Japan and MEA will exhibit a sluggish growth during the forecast period.
3. Biopsy tests will continue to exhibit the highest CAGR through 2022, among test type in the global market, followed by LFTs.
4. AFP test is projected to remain sought-after for liver cancer diagnostics over the forecast period. Revenues from AFP tests are estimated to hold more than half market share in 2017, and are expected to attain 52 BPS in their market share by 2022-end.

For critical insights on this market, request for methodology here https://www.factmr.com/connectus/sample?flag=RM&rep_id=73

1. Hospital-associated labs are expected to remain sought-after in the market for liver cancer diagnostics. Liver cancer diagnostics in the hospital-associated labs are expected to account for largest revenues during the forecast period.
2. Independent diagnostic laboratories will continue to be the second most lucrative segment among end-users in the global market for liver cancer diagnostics.
3. Diagnosis of liver cancer in cancer research institutes will continue to register the highest CAGR over the forecast period.

The report has also profiled companies that will remain active in expansion of global liver cancer diagnostics market through 2022. These include Illumina, Inc.
Sysmex Corporation, Danaher Corporation, Biocept, Inc., and Foundation Medicine, Inc.

For More Insights- https://www.biospace.com/article/ongoing-research-and-progress-in-clinical-trials-are-creating-growth-prospects-for-non-hormonal-steroid-modulators-market-fact-mr/

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com